Skip to main content
Complex Psychiatry logoLink to Complex Psychiatry
. 2020 Oct 1;6(3-4):83–88. doi: 10.1159/000511887

Transcriptomic Deconvolution of Dorsal Striata Reveals Increased Monocyte Fractions in Bipolar Disorder

Sai Batchu 1,*
PMCID: PMC7923883  PMID: 34883498

Abstract

Introduction

Accumulating evidence suggests a relationship between the immune system, neuroinflammation, and mood disorders such as bipolar disorder (BD). However, the immunological landscape of critical brain structures implicated with BD, such as the dorsal striatum, has yet to be characterized. This study sought to investigate the immunological composition of dorsal striata in patients with BD.

Methods

CIBERSORTx, an established RNA deconvolution algorithm, was applied on RNA-sequencing data developed from dorsal striata of 18 BD patients and 17 controls. A validated gene signature matrix for 22 human hematopoietic cell subsets was used to infer the relative proportions of immune cells that were present in the original brain tissue.

Results

Deconvolution of the bulk gene expression data showed that dorsal striata from BD subjects had a significantly greater relative abundance of monocytes compared to control samples.

Conclusion

Monocytes may play a role in the pathogenesis of BD in dorsal striata. Further studies are warranted to confirm the computational results presented herein.

Keywords: Neuroinflammation, Bipolar disorder, Monocytes, RNA deconvolution

Introduction

Bipolar disorder (BD) is a heterogeneous mental illness characterized by interspersed episodes of mania or hypomania, usually intermixed with bouts of depression. Studies have shown such manic episodes often present with impulsive, risk-taking behavior [1, 2]. Certain models for BD implicate reward-predicting stimuli, and abnormal processing thereof, in the mental illness [3]. From these models evolved the hypothesis that the dorsal striatum, a region of the brain implicated in processing reward and risk information, is involved in BD pathogenesis [4]. Not only is this proposition supported by the fact that dorsal striatum is involved in action-contingent learning and is one of the main input areas for the basal ganglia, but also because previous imaging studies have shown aberrations in function and volume of the striatum in BD subjects [5, 6, 7].

In addition to elucidating the dorsal striatum as one of the major brain structures in BD, evidence has accumulated for the involvement of the immune system in mood disorders [8, 9, 10, 11]. The majority of case-control studies have discovered that BD patients have increased proinflammatory cytokines during manic episodes compared with controls [12, 13, 14, 15, 16, 17, 18, 19, 20]. One recently proposed theory postulates that reduced maturation of T-regulatory cells plays a role in the progression of BD [21]. These studies that have described immune alterations in the periphery have led to the theory that neuroinflammation, defined broadly as the inflammatory state of the central nervous system, plays a role in BD. Indeed, recent transcriptomic analyses have enriched pathways and discovered differentially expressed genes involved in immune system regulation from brains of postmortem BD subjects [22].

Although previous work has shown a putative role of the immune system in BD, most studies involving the brain have focused on microglia, with no substantial evidence for microglial immune activation [23, 24, 25, 26, 27]. Thus, it is imperative to search for the involvement of other immune elements. There has been no investigation to date, as per our knowledge, characterizing the broad spectrum of immune cell subtypes as possible infiltrates in BD-implicated brain structures. Therefore, the present study explored the immune composition of dorsal striata from 18 BD subjects and 17 control subjects through digital cytometry. Bulk RNA-sequencing data derived from dorsal striata were computationally profiled to estimate relative proportions of immune subsets present in the original tissue. The proportions of immune cell subtypes were compared between BD patients and control subjects to examine any differences. It was found that dorsal striata from BD patients were comprised of significantly more monocytes. The present work underscores the importance of examining the striatum to explore possible immune factors involved in BD, which may aid in development of novel neuroinflammation-based therapies.

Materials and Methods

The dataset used for deconvolution consists of human postmortem dorsal striatum gene expression data for 18 BD patients and 18 control subjects (Table 1) [27]. The frozen postmortem samples were retrieved from the Harvard Brain Tissue Resource Center (Belmont, MA, USA). The groups were comparable as no significant differences were found in terms of age, sex, RNA integrity number, and postmortem interval [27]. The read count data are readily available in the Gene Expression Omnibus database (GEO) database (http://www.ncbi.nlm.nih.gov/geo) under accession GSE80336. Since the data are publicly available, approval to conduct the present study by an institutional review board was not required.

Table 1.

Demographics of bipolar and control subjects

Status Age, years Sex PMI
Control 65.0±15.7 10 F/7 M 22.8±6.4
Bipolar 69.7±15.3 12 F/6 M 25.1±15.8

Adapted from Pacifico and Davis [27]. F, female; M, male; PMI, postmortem interval. Age and PMI reported as mean ± standard deviation.

As per the original study, the raw reads were generated with the Illumina HiSeq2000 platform and were processed by removing low quality base calls with PHRED score <30 and contaminating adapter sequences. Reads were then aligned with BowTie2 [28] to a custom ribosomal DNA reference to remove those aligning to ribosomal RNA genes. TopHat (v2.0.12) [29] mapped the remaining reads against the reference human genome GRCh38. HTSeq-count within HTSeq (v0.6.0) was run in union mode [30]. TopHat and HTSeq parameters included a reverse setting for library strandedness with other parameters set as default. For the present study, the read count matrix was retrieved from the GEO database and gene length normalized in transcripts per million space prior to analysis with CIBERSORTx. However, 1 control subject was removed from further analysis due to being an outlier after visualization through hierarchal clustering based on Euclidean distance [27].

CIBERSORTx, an established machine-learning RNA deconvolution algorithm, was implemented to provide an estimation of the relative abundances of immune cells from the original previously published gene expression dataset described above [31] (shown in Fig. 1). Although other deconvolution methodologies are available, such as least-square regression and microarray microdissection, these algorithms are sensitive to experimental noise, closely related cell types, and unknown mixture content, which limits their ability to enumerate cell type proportions [32, 33, 34]. CIBERSORTx differs from these methods by implementing support vector regression, a machine-learning approach that improves deconvolution ability through feature selection and allows resolution of closely related subsets. Furthermore, the algorithm accurately quantifies the relative fractions of distinct cell types within a complex gene expression mixture given a priori cell type-specific gene signatures. Specifically, the algorithm requires (1) a matrix of bulk tissue gene expression profiles to be deconvoluted and (2) a signature matrix containing signature gene expression profiles for cell subsets of interest. To estimate the proportion of a specific cell type, the algorithm assesses the relative expression changes of signature genes related to the cell type of interest compared with the expression of all other genes in the sample [31].

Fig. 1.

Fig. 1

Illustration of workflow. Previously published RNA-sequencing data from bulk dorsal striata were retrieved and deconvoluted through machine learning, allowing for estimation of cell types present in the original tissue.

To estimate the amount of immune cell subtypes, a validated signature matrix containing a total of 547 genes for distinguishing 22 human hematopoietic cell subsets, termed “LM22,” was used to deconvolute the bulk dorsal striata gene mixture matrix [31]. The CIBERSORTx algorithm was run with bulk-mode batch correction and 500 permutations in relative mode. Quantile normalization was not implemented as dataset was generated from RNA-sequencing. Deconvoluted samples were deemed significant if CIBERSORTx p value <0.05, which represents the significance of the deconvolution results across all cell subsets for goodness-of-fit. This p value is determined for each sample using Monte Carlo sampling, effectively providing a confidence measure in the results [31]. The data output from CIBERSORTx was downloaded and analyzed with R programming language.

The relative proportions estimated by the algorithm for each cell subtype were compared between BD patients and control subjects. Normality was tested with the Shapiro-Wilk method and visually inspected through a Q-Q plot. Homogeneity of variance was tested with Levene's test. Differences between group means were tested by the two-sided Student's t test assuming equal variance or with Welch's test for heteroskedastic cell subtypes. If the normality assumption was not met, the non-parametric Mann Whitney U test was used for comparisons. A false discovery rate-adjusted p value <0.05 was deemed significant (Benjamini-Hochberg).

Results

After RNA deconvolution for immune cell subset identification, all 35 samples were significant at the criteria for CIBERSORTx p value <0.05 and were deemed suitable for further analysis. When comparing relative abundances between BD subjects and controls, BD dorsal striata exhibited a significantly higher monocyte fraction (shown in Fig. 2) (p = 0.013). The algorithm estimated the relative fractions of this cell type through unique signature genes specific to monocytes taken from the input LM22 signature matrix (Table 2) [31]. Significant changes in the relative proportions were not observed amongst the other 21 immune cell subtypes evaluated, including related subtypes such as M2 and M1 macrophages.

Fig. 2.

Fig. 2

Bar plot displaying mean relative proportions of immune cells estimated from dorsal striata of BD subjects and CNTRL. Asterisk (*) denotes significance at p < 0.05. Error bars indicate 95% confidence intervals. BD, bipolar disorder; CNTRL, controls.

Table 2.

Signature genes used for monocyte relative enumeration

AIF1 CHST15 HNMT NOD2
APOBEC3A CLEC4A HPSE P2RY13
AQP9 CLEC7A IGSF6 PADI4
ASGR1 CREB5 LILRA2 RNASE2
ASGR2 CSF3R LILRA3 RNASE6
BST1 FAM198B LILRB2 S100A12
C5AR1 FCN1 LST1 SLC15A3
CCR2 FES MEFV TLR2
CD1D FOSB MNDA TLR7
CD33 FPR1 MS4A6A TLR8
CD68 FZD2 NCF2 UPK3A
CDA HCK NFE2 VNN1
CFP HK3 NLRP3 VNN2

Discussion/Conclusion

As presented here, the digital dissection of the immunological landscape from existing gene expression data has shown a bias for monocytes in dorsal striata of BD subjects. These findings corroborate a previous report that implicates monocytes in the pathophysiology of BD. Jakobsson et al. [32] found increased levels of monocyte chemoattractant protein-1 and chitinase-3-like protein-1 (YKL-40) in cerebrospinal fluid from patients with BD. These proteins are primarily secreted by cells of monocytic origin and have been associated with neuroinflammation in neurologic disorders [33]. Although these proteins were measured in cerebrospinal fluid as opposed to brain tissue, cerebrospinal fluid marker levels have been shown to accurately reflect immunological activity in the brain [34, 35]. Marzi et al. [36] also observed an increased frequency of circulating monocytes in the plasma of BD patients. The explanations regarding this inflammatory profile can be summarized as follows: (1) stress precipitated by mood episodes may increase monocytes; (2) increased monocytes trigger mood disorder as proposed by the macrophage theory of depression [37]; (3) there is a common factor underlying both BD and increased monocyte frequency; or (4) monocyte overabundance and BD are actually 2 separate entities caused by 2 different factors present in the same environment [38]. Nonetheless, further studies are required to elucidate the purpose and relevance of monocytes in BD.

A limitation of the current study is the in silico approach to deconvolute gene expression data from bulk tissue sample. The data processing does not account for the spatial relationship of tissue and cytoarchitecture. Further studies are required to confirm the present computationally derived results. It is also important to note that an increased blood-brain barrier permeability in patients with BD may be a potential confounder in this study. Disruptions in the blood-brain barrier integrity may cause an abnormal influx of proinflammatory substances, such as immune cells, from peripheral blood into brain parenchyma [39]. Nonetheless, this digital cytometric technique has previously replicated conventional flow cytometry data with significant clinical implications [40, 41, 42, 43]. Although medication use and mood state were unknown in the current cohort, and therefore could not be controlled for, this current article is the first to characterize possible differences in immune cell subtype composition in brain tissue, specifically among dorsal striata, in BD through an unbiased computational perspective.

Based on the hypothesis-generating data presented here, further studies are warranted to elucidate whether this immune element of BD is a causal factor of the illness or is a finding precipitated by the illness itself. In conclusion, the digital approach used herein resolved monocytes as potential immune infiltrates in dorsal striata of BD subjects.

Statement of Ethics

Not applicable. This article does not contain any studies with human participants performed by the author.

Conflict of Interest Statement

The author has no conflicts of interest to declare.

Funding Sources

No funding was received for this study. The content is solely the responsibility of the author and does not necessarily represent the official views of Cooper Medical School of Rowan University.

Author Contributions

S.B. formulated design and analyzed data. Results were interpreted by S.B. Manuscript was written and edited by S.B. All authors read and approved the final manuscript.

References

  • 1.Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry. 2001 Nov;158((11)):1783–93. doi: 10.1176/appi.ajp.158.11.1783. [DOI] [PubMed] [Google Scholar]
  • 2.Strakowski SM, Fleck DE, DelBello MP, Adler CM, Shear PK, McElroy SL, et al. Characterizing impulsivity in mania. Bipolar Disord. 2009 Jan;11((1)):41. doi: 10.1111/j.1399-5618.2008.00658.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Alloy LB, Nusslock R, Boland EM. The development and course of bipolar spectrum disorders: an integrated reward and circadian rhythm dysregulation model. Annu Rev Clin Psychol. 2015 Jan;11:213–50. doi: 10.1146/annurev-clinpsy-032814-112902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Yanike M, Ferrera VP. Representation of outcome risk and action in the anterior caudate nucleus. J Neurosci. 2014 Feb;34((9)):3279–90. doi: 10.1523/JNEUROSCI.3818-13.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ferrera SM, DelBello MP, Sax KW, Zimmerman ME, Shear PK, Hawkins JM, et al. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry. 1999 March;56((3)):254–60. doi: 10.1001/archpsyc.56.3.254. [DOI] [PubMed] [Google Scholar]
  • 6.Blumberg HP, Martin A, Kaufman J, Leung HC, Skudlarski P, Lacadie C, et al. Frontostriatal abnormalities in adolescents with bipolar disorder: preliminary observations from functional MRI. Am J Psychiatry. 2003 Jul;160((7)):1345–7. doi: 10.1176/appi.ajp.160.7.1345. [DOI] [PubMed] [Google Scholar]
  • 7.Wessa M, Houenou J, Paillère-Martinot ML, Berthoz S, Artiges E, Leboyer M, et al. Fronto-striatal overactivation in euthymic bipolar patients during an emotional go/nogo task. Am J Psychiatry. 2007 Apr;164((4)):638–46. doi: 10.1176/ajp.2007.164.4.638. [DOI] [PubMed] [Google Scholar]
  • 8.Keshavarz M. Glial cells as key elements in the pathophysiology and treatment of bipolar disorder. Acta Neuropsychiatr. 2017;29((3)):140–52. doi: 10.1017/neu.2016.56. [DOI] [PubMed] [Google Scholar]
  • 9.Watkins CC, Sawa A, Pomper MG. Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application. Transl Psychiatry. 2014;4:e350. doi: 10.1038/tp.2013.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.McNamara RK, Lotrich FE. Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? Expert Rev Neurother. 2012 Sep;12((9)):1143–61. doi: 10.1586/ern.12.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder. J Clin Psychiatry. 2009 Aug;70((8)):1078–90. doi: 10.4088/JCP.08r04505. [DOI] [PubMed] [Google Scholar]
  • 12.Brietzke E, Stertz L, Fernandes BS, Kauer-Santʼanna M, Mascarenhas M, Escosteguy Vargas A, et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord. 2009;116((3)):214–7. doi: 10.1016/j.jad.2008.12.001. [DOI] [PubMed] [Google Scholar]
  • 13.Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res. 1995 April;29((2)):141–52. doi: 10.1016/0022-3956(94)00049-w. [DOI] [PubMed] [Google Scholar]
  • 14.Kim YK, Jung HG, Myint AM, Kim H, Park SH. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord. 2007 Dec;104((1–3)):91–5. doi: 10.1016/j.jad.2007.02.018. [DOI] [PubMed] [Google Scholar]
  • 15.O'Brien SM, Scully P, Scott LV, Dinan TG. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord. 2006 Feb;90((2–3)):263–7. doi: 10.1016/j.jad.2005.11.015. [DOI] [PubMed] [Google Scholar]
  • 16.Ortiz-Domínguez A, Hernández ME, Berlanga C, Gutiérrez-Mora D, Moreno J, Heinze G, et al. Immune variations in bipolar disorder: phasic differences. Bipolar Disord. 2007 Sep;9((6)):596–602. doi: 10.1111/j.1399-5618.2007.00493.x. [DOI] [PubMed] [Google Scholar]
  • 17.Breunis MN, Kupka RW, Nolen WA, Suppes T, Denicoff KD, Leverich GS, et al. High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder. Biol Psychiatry. 2003 Jan;53((2)):157–65. doi: 10.1016/s0006-3223(02)01452-x. [DOI] [PubMed] [Google Scholar]
  • 18.Padmos RC, Hillegers MH, Knijff EM. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry. 2008 Apr;65((4)):395–407. doi: 10.1001/archpsyc.65.4.395. [DOI] [PubMed] [Google Scholar]
  • 19.Tsai SY, Chen KP, Yang YY, Chen CC, Lee JC, Singh VK, et al. Activation of indices of cell-mediated immunity in bipolar mania. Biol Psychiatry. 1999 Apr;45((8)):989–94. doi: 10.1016/s0006-3223(98)00159-0. [DOI] [PubMed] [Google Scholar]
  • 20.Tsai SY, Yang YY, Kuo CJ, Chen CC, Leu SJ. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania. J Affect Disord. 2001 May;64((2–3)):185–93. doi: 10.1016/s0165-0327(00)00252-4. [DOI] [PubMed] [Google Scholar]
  • 21.Grosse L, Hoogenboezem T, Ambrée O, Bellingrath S, Jörgens S, de Wit HJ, et al. Deficiencies of the T and natural killer cell system in major depressive disorder: T regulatory cell defects are associated with inflammatory monocyte activation. Brain Behav Immun. 2016 May;54:38–44. doi: 10.1016/j.bbi.2015.12.003. [DOI] [PubMed] [Google Scholar]
  • 22.Hercher C, Chopra V, Beasley CL. Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder. J Psychiatry Neurosci. 2014 Nov;39((6)):376–85. doi: 10.1503/jpn.130277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Brisch R, Steiner J, Mawrin C, Krzyżanowska M, Jankowski Z. Gos T. Microglia in the dorsal raphe nucleus plays a potential role in both suicide facilitation and prevention in affective disorders. Eur Arch Psychiatry Clin Neurosci. 2017 Aug;267((5)):403–15. doi: 10.1007/s00406-017-0774-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gos M, Drevets WC, Price JL. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol Psychiatry. 2004;55((6)):563–9. doi: 10.1016/j.biopsych.2003.11.006. [DOI] [PubMed] [Google Scholar]
  • 25.Dean B, Gibbons AS, Tawadros N, Brooks L, Everall P, Scarr E. Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders. Mol Psychiatry. 2013;18((7)):767–73. doi: 10.1038/mp.2012.95. [DOI] [PubMed] [Google Scholar]
  • 26.Scarr MAM, Snijders GJLJ, Berdowski WM, Fernández-Andreu A, van Mierlo HC, van Mierlo HC, et al. Microglia in post-mortem brain tissue of patients with bipolar disorder are not immune activated. Transl Psychiatry. 2019 May 24;9((1)):153. doi: 10.1038/s41398-019-0490-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Pacifico R, Davis RL. Transcriptome sequencing implicates dorsal striatum-specific gene network, immune response and energy metabolism pathways in bipolar disorder. Mol Psychiatry. 2017 June;22((3)):441–9. doi: 10.1038/mp.2016.94. [DOI] [PubMed] [Google Scholar]
  • 28.Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9((4)):357–9. doi: 10.1038/nmeth.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14((4)):R36. doi: 10.1186/gb-2013-14-4-r36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Anders S, Pyl PT, Huber W. HTSeq: a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31((2)):166–9. doi: 10.1093/bioinformatics/btu638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019 Jul;37((7)):773–82. doi: 10.1038/s41587-019-0114-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Jakobsson J, Bjerke M, Sahebi S, Isgren A, Ekman CJ, Sellgren C, et al. Monocyte and microglial activation in patients with mood-stabilized bipolar disorder. J Psychiatry Neurosci. 2015 Jul;40((4)):250–8. doi: 10.1503/jpn.140183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lautner R, Mattsson N, Schöll M. Biomarkers for microglial activation in Alzheimer's disease. Int J Alzheimers Dis. 2011;2011:939426. doi: 10.4061/2011/939426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bromander S, Anckarsater R, Anckarsäter M, Blennow K, Zetterberg H, Anckarsäter H, et al. Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study. J Neuroinflammation. 2012;9:242. doi: 10.1186/1742-2094-9-242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Maier B, Laurer HL, Rose S, Buurman WA, Marzi I. Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study. J Neurotrauma. 2005;22((7)):822–35. doi: 10.1089/neu.2005.22.822. [DOI] [PubMed] [Google Scholar]
  • 36.Marzi IG, Rocha NP, Assis F, Vieira ÉL, Soares JC, Bauer ME, et al. Monocyte and lymphocyte activation in bipolar disorder: a new piece in the puzzle of immune dysfunction in mood disorders. Int J Neuropsychopharmacol. 2014 Oct 31;18((1)):pyu021. doi: 10.1093/ijnp/pyu021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Smith RS. The macrophage theory of depression. Med Hypotheses. 1991 Aug;35((4)):298–306. doi: 10.1016/0306-9877(91)90272-z. [DOI] [PubMed] [Google Scholar]
  • 38.Padmos RC, Van Baal GC, Vonk R, Wijkhuijs AJ, Kahn RS, Nolen WA, et al. Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study. Arch Gen Psychiatry. 2009 Sep;66((9)):957–65. doi: 10.1001/archgenpsychiatry.2009.116. [DOI] [PubMed] [Google Scholar]
  • 39.Patel JP, Frey BN. Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder? Neural Plast. 2015;2015:708306. doi: 10.1155/2015/708306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018 Jan;1711:243–59. doi: 10.1007/978-1-4939-7493-1_12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Rohr-Udilova N, Klinglmüller F, Schulte-Hermann R, Stift J, Herac M, Salzmann M, et al. Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma. Sci Rep. 2018 April;8((1)):6220. doi: 10.1038/s41598-018-24437-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Tang G, Yin W. Development of an immune infiltration-related prognostic scoring system based on the genomic landscape analysis of glioblastoma multiforme. Front Oncol. 2020 Feb;10:154. doi: 10.3389/fonc.2020.00154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Yang S, Liu T, Cheng Y, Bai Y, Liang G. Immune cell infiltration as a biomarker for the diagnosis and prognosis of digestive system cancer. Cancer Sci. 2019 Oct;110((12)):3639–49. doi: 10.1111/cas.14216. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Complex Psychiatry are provided here courtesy of Karger Publishers

RESOURCES